"FDA seeks, under its Office of Scientific and Medical programs, its public health mission, and its Critical Path Initiative, to award a contract for the development of an infrastructure to support a multidisciplinary, multi-phased nanotechnology program and subsequent related studies as identified in: “Seven Challenges for Nanomedicine ” Nature Nanotechnology Vol 3, May 2008”. Such an infrastructure will include, but will not be limited to, co-development of study priorities, clinical and non-clinical protocols, and publications at specified program milestones related to the scientific and regulatory priorities under FDA’s mission."
Specific project objectives include:
- Establishing an administrative and scientific infrastructure to implement and manage a collaborative nanotechnology program;
- Managing a collaborative infrastructure for fostering additional concepts or ideas involving joint projects or integrated approaches to science or technology development specifically aimed at developing nanoengineered products;
- Assembling a multi-disciplinary research team and developing study protocols in priority areas;
- Developing strategies to address safety of nanoparticles in a broad spectrum of products under FDA’s jurisdiction....
See the complete solicitation for detailed description and submission information.
